CClinicalTrials.gg
CompletedNCT04295239NEMOCARDUpdated Jul 29, 2024

Non-invasive Monitoring of Cerebral Autoregulation in Perioperative Neonatal Cardiac Surgery

An interventional study of MRI in Congenital Heart Disease in Children and Extracorporeal Circulation; Complications, sponsored by Nantes University Hospital. Completed at 1 site in France. Open to participants aged 0 Days to 28 Days. Per ClinicalTrials.gov, last updated 2024-07-29.

Sponsored by Nantes University Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
0 Days to 28 Days
Sex
All
01

Study summary

Cardiac surgery under extracorporeal circulation (ECC) in newborns with congenital heart disease causes significant morbidity and mortality. The perioperative period is a period of major vulnerability implicated in the appearance of these sequelae, and it is therefore essential to monitor brain function during ECC. The quality of cerebral oxygenation in the perioperative period is routinely monitored non-invasively by infra-red spectroscopy, which makes it possible to estimate cerebral tissue oximetry from a surface electrode (NIRS). The association between time spent outside the limits of cerebral autoregulation and the occurrence of perioperative encephalopathy is not known. The purpose of this study is to determine whether disturbances in brain autoregulation during the operative period are associated with the occurrence of postoperative encephalopathy in children operated on for congenital heart disease in the neonatal period. The main objective of the research is to determine the association between time spent outside individually determined cerebral autoregulation limits and the appearance of brain lesions suggestive of low brain output. Secondary objectives will investigate the association between time spent outside autoregulatory limits and the occurrence of postoperative encephalopathy defined by clinical and encephalographic criteria and will study factors predictive of the development of postoperative encephalopathy.

02

Conditions studied

  • Congenital Heart Disease in Children
  • Extracorporeal Circulation; Complications
03

In context

Heart Diseases

3,639 studies on the registry are indexed under Heart Diseases; 461 are open to participants now.

This study's enrollment of 40 is below the median of 100 across 1,778 interventional studies indexed under Heart Diseases.

Browse Heart Diseases studies →

Lead sponsor

Nantes University Hospital is the lead sponsor of 825 studies on the registry; 195 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
0 Days to 28 Days
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Any newborn (0-28 days) with congenital heart disease, hospitalized in the preoperative period at the Nantes University Hospital, for whom a decision is made to perform an operation under extracorporeal circulation, suitable to be transported for an MRI without risk, advice taken from the treating team.

Exclusion criteria

Exclusion Criteria:

  • emergency cardiac surgery
  • Preoperative extracorporeal assistance
  • Preoperative intubation
  • Preoperative administration of inotropes
  • Pre-operative instability contra-indicating pre-operative MRI
  • Dependence on a pace maker contra-indicating MRI Imaging.
  • Parental consent refusal
  • Non-affiliation to a health security insurance
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    MRI

    Pre-operative AND post-operative MRI

    Procedure: MRI

Interventions

  • ProcedureMRI

    Pre and Post operative MRI

06

What researchers measure

Primary outcomes

  1. determine the association between time spent outside individually determined cerebral autoregulation limits and the development of brain lesions suggestive of low brain output.

    duration of period outside cerebral autoregulation limits, Number, size and extent of new lesions on post-operative MRI. Patients will be classified into 2 categories according to whether or not there are new lesions on MRI. The lesions retained will be infarcts, white matter lesions and intraparenchymal hemorrhages, classified according to the Magnetic Resonance Imaging Abnormality Scoring System.

    Time frame: 6 weeks after cardiac surgery

Secondary outcomes

  1. describe association between time spent outside autoregulation limits and the occurrence of postoperative encephalopathy defined by clinical and encephalographic criteria.

    duration of period outside cerebral autoregulation limits, Standardized clinical examination according to Amiel Tison at hospital discharge.

    Time frame: 6 weeks after cardiac surgery

  2. describe predictive factors of postoperative encephalopathy

    duration of extra-corporal circulation,

    Time frame: day 1 (cardiac surgery)

  3. describe predictive factors of postoperative encephalopathy

    duration of aortic clamp

    Time frame: day 1 (cardiac surgery)

  4. describe predictive factors of postoperative encephalopathy

    duration of selective cerebral perfusion,

    Time frame: day 1 (cardiac surgery)

  5. describe predictive factors of postoperative encephalopathy

    duration of hypothermia deepness

    Time frame: day 1 (cardiac surgery)

  6. describe predictive factors of postoperative encephalopathy

    duration of critical NIRS

    Time frame: day 1 (cardiac surgery)

  7. describe predictive factors of postoperative encephalopathy

    duration of critical median arterial pression (PAM)

    Time frame: day 1 (cardiac surgery)

07

Study locations

1 site
  • Chu de Nantes
    Nantes, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04295239
Lead sponsor
Nantes University Hospital
Responsible party
Sponsor
First posted
Mar 4, 2020
Start date
Mar 10, 2020
Primary completion
Feb 19, 2022
Completion
Feb 19, 2022
Last update
Jul 29, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion